Epstein-Barr	O
viral	O
latency	O
is	O
disrupted	O
by	O
the	O
immediate-early	B-protein
BRLF1	I-protein
protein	I-protein
through	O
a	O
cell-specific	O
mechanism	O
.	O

Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
,	O
the	O
causative	O
agent	O
of	O
infectious	O
mononucleosis	O
,	O
is	O
a	O
human	O
herpesvirus	O
associated	O
with	O
epithelial	O
cell	O
malignancies	O
(	O
nasopharyngeal	O
carcinoma	O
)	O
as	O
well	O
as	O
B-cell	O
malignancies	O
.	O

Understanding	O
how	O
viral	O
latency	O
is	O
disrupted	O
is	O
a	O
central	O
issue	O
in	O
herpesvirus	O
biology	O
.	O

Epithelial	O
cells	O
are	O
the	O
major	O
site	O
of	O
lytic	O
EBV	O
replication	O
within	O
the	O
human	O
host	O
,	O
and	O
viral	O
reactivation	O
occurs	O
in	O
EBV-associated	O
nasopharyngeal	O
carcinomas	O
.	O

It	O
is	O
known	O
that	O
expression	O
of	O
a	O
single	O
viral	B-protein
immediate-early	I-protein
protein	I-protein
,	O
BZLF1	B-protein
,	O
is	O
sufficient	O
to	O
initiate	O
the	O
switch	O
from	O
latent	O
to	O
lytic	O
infection	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

Cellular	O
regulation	O
of	O
BZLF1	B-protein
transcription	O
is	O
therefore	O
thought	O
to	O
play	O
a	O
key	O
role	O
in	O
regulating	O
the	O
stringency	O
of	O
viral	O
latency	O
.	O

Here	O
we	O
show	O
that	O
,	O
unexpectedly	O
,	O
expression	O
of	O
another	O
viral	B-protein
immediate-early	I-protein
protein	I-protein
,	O
BRLF1	B-protein
,	O
can	O
disrupt	O
viral	O
latency	O
in	O
an	O
epithelial	O
cell-specific	O
fashion	O
.	O

Therefore	O
,	O
the	O
mechanisms	O
leading	O
to	O
disruption	O
of	O
EBV	O
latency	O
appear	O
to	O
be	O
cell-type	O
specific	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

93	NULL
,	NULL
pp	NULL
.	NULL

9194-9199	NULL
,	NULL
August	NULL
1996	NULL
Microbiology	NULL
Epstein-Barr	NULL
viral	NULL
latency	NULL
is	NULL
disrupted	NULL
by	NULL
the	NULL
immediate-early	NULL
protein	NULL
through	NULL
a	NULL
cell-specific	NULL
mechanism	NULL
(	NULL
viral	NULL
reactivation	NULL
/BZLF1/Epstein-Barr	NULL
virus	NULL
)	NULL
SUNITA	NULL
ZALANI®	NULL
,	NULL
ELIZABETH	NULL
HoLLEY-GUTHRIE*	NULL
,	NULL
AND	NULL
SHANNON	NULL
KenneEy*t	NULL
$	NULL
§	NULL
Departments	NULL
of	NULL
*Medicine	NULL
and	NULL
*Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
*Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599	NULL
Communicated	NULL
by	NULL
Bernard	NULL
Roizman	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
,	NULL
May	NULL
10	NULL
,	NULL
1996	NULL
(	NULL
received	NULL
for	NULL
review	NULL
January	NULL
31	NULL
,	NULL
1996	NULL
)	NULL
ABSTRACT	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
the	NULL
causative	NULL
agent	NULL
of	NULL
infectious	NULL
mononucleosis	NULL
,	NULL
is	NULL
a	NULL
human	NULL
herpesvirus	NULL
associated	NULL
with	NULL
epithelial	NULL
cell	NULL
malignancies	NULL
(	NULL
nasopharyngeal	NULL
carcinoma	NULL
)	NULL
as	NULL
well	NULL
as	NULL
B-cell	NULL
malignancies	NULL
.	NULL

Understanding	NULL
how	NULL
viral	NULL
latency	NULL
is	NULL
disrupted	NULL
is	NULL
a	NULL
central	NULL
issue	NULL
in	NULL
herpesvirus	NULL
biology	NULL
.	NULL

Epithelial	NULL
cells	NULL
are	NULL
the	NULL
major	NULL
site	NULL
of	NULL
lytic	NULL
EBV	NULL
replication	NULL
within	NULL
the	NULL
human	NULL
host	NULL
,	NULL
and	NULL
viral	NULL
reactivation	NULL
occurs	NULL
in	NULL
EBV-associated	NULL
nasopharyngeal	NULL
carcinomas	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
single	NULL
viral	NULL
immediate-early	NULL
protein	NULL
,	NULL
BZLF1	NULL
,	NULL
is	NULL
sufficient	NULL
to	NULL
initiate	NULL
the	NULL
switch	NULL
from	NULL
latent	NULL
to	NULL
lytic	NULL
infection	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Cellular	NULL
regulation	NULL
of	NULL
BZLF1	NULL
transcription	NULL
is	NULL
therefore	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
stringency	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
,	NULL
unexpectedly	NULL
,	NULL
expression	NULL
of	NULL
another	NULL
viral	NULL
immediate-early	NULL
protein	NULL
,	NULL
BRLF1	NULL
,	NULL
can	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
an	NULL
epithelial	NULL
cell-specific	NULL
fashion	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
mechanisms	NULL
leading	NULL
to	NULL
disruption	NULL
of	NULL
EBV	NULL
latency	NULL
appear	NULL
to	NULL
be	NULL
cell-type	NULL
specific	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
human	NULL
herpesvirus	NULL
associated	NULL
with	NULL
lymphoid	NULL
and	NULL
epithelial	NULL
cell	NULL
malignancies	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

A	NULL
critical	NULL
aspect	NULL
of	NULL
herpesvirus	NULL
biology	NULL
is	NULL
the	NULL
maintenance	NULL
and	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

EBV	NULL
infection	NULL
is	NULL
generally	NULL
latent	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
commonly	NULL
productive	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

EBV	NULL
reactivation	NULL
and	NULL
replication	NULL
in	NULL
latently	NULL
infected	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
agents	NULL
such	NULL
as	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
or	NULL
cross-linking	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

These	NULL
agents	NULL
activate	NULL
expression	NULL
of	NULL
the	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
protein	NULL
,	NULL
BZLF1	NULL
(	NULL
Z	NULL
)	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Z	NULL
,	NULL
a	NULL
transcriptional	NULL
activator	NULL
,	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
basic	NULL
leucine	NULL
zipper	NULL
(	NULL
bZip	NULL
)	NULL
family	NULL
which	NULL
binds	NULL
to	NULL
AP1-like	NULL
Z-response	NULL
elements	NULL
in	NULL
EBV	NULL
early	NULL
promoters	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
Z	NULL
in	NULL
latently	NULL
infected	NULL
lymphocytes	NULL
is	NULL
sufficient	NULL
to	NULL
trigger	NULL
the	NULL
lytic	NULL
cycle	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Z	NULL
,	NULL
EBV	NULL
has	NULL
one	NULL
other	NULL
IE	NULL
protein	NULL
,	NULL
BRLF1	NULL
(	NULL
R	NULL
)	NULL
.	NULL

Like	NULL
Z	NULL
,	NULL
R	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
and	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
(	NULL
16-22	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
early	NULL
EBV	NULL
promoters	NULL
contain	NULL
upstream	NULL
R	NULL
binding	NULL
sites	NULL
(	NULL
a	NULL
G+C-rich	NULL
motif	NULL
)	NULL
and	NULL
are	NULL
transcriptionally	NULL
activated	NULL
by	NULL
R	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

Certain	NULL
early	NULL
viral	NULL
promoters	NULL
require	NULL
both	NULL
Z	NULL
and	NULL
R	NULL
for	NULL
maximal	NULL
transcriptional	NULL
activation	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
21	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Z	NULL
,	NULL
expression	NULL
of	NULL
transfected	NULL
R	NULL
in	NULL
EBV-infected	NULL
B	NULL
cells	NULL
does	NULL
not	NULL
disrupt	NULL
latency	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
expression	NULL
of	NULL
Z	NULL
is	NULL
sufficient	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
has	NULL
led	NULL
to	NULL
a	NULL
model	NULL
in	NULL
which	NULL
lytic	NULL
EBV	NULL
infection	NULL
results	NULL
from	NULL
activation	NULL
of	NULL
BZLFI1	NULL
transcription	NULL
by	NULL
cellular	NULL
transcription	NULL
factors	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
Z	NULL
protein	NULL
can	NULL
potentially	NULL
be	NULL
derived	NULL
from	NULL
two	NULL
different	NULL
promoters	NULL
,	NULL
Zp	NULL
and	NULL
Rp	NULL
(	NULL
16	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
more	NULL
proximal	NULL
promoter	NULL
,	NULL
Zp	NULL
(	NULL
from	NULL
which	NULL
most	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
Z	NULL
protein	NULL
is	NULL
derived	NULL
)	NULL
,	NULL
directs	NULL
transcription	NULL
of	NULL
a	NULL
1.0-kb	NULL
message	NULL
encoding	NULL
the	NULL
Z	NULL
protein	NULL
alone	NULL
.	NULL

The	NULL
distal	NULL
promoter	NULL
,	NULL
Rp	NULL
,	NULL
directs	NULL
transcription	NULL
of	NULL
a	NULL
2.8-kb	NULL
message	NULL
encoding	NULL
the	NULL
R	NULL
protein	NULL
,	NULL
and	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

9194	NULL
potentially	NULL
the	NULL
Z	NULL
protein	NULL
as	NULL
well	NULL
(	NULL
if	NULL
the	NULL
message	NULL
can	NULL
be	NULL
bicistronically	NULL
translated	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Zp	NULL
and	NULL
Rp	NULL
are	NULL
normally	NULL
inactive	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
,	NULL
but	NULL
agents	NULL
that	NULL
disrupt	NULL
viral	NULL
latency	NULL
such	NULL
as	NULL
PMA	NULL
and	NULL
anti-immunoglobulin	NULL
activate	NULL
expression	NULL
of	NULL
Zp	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Rp	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

Although	NULL
the	NULL
phenotype	NULL
of	NULL
virus	NULL
lacking	NULL
Z	NULL
or	NULL
R	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
both	NULL
Z	NULL
and	NULL
R	NULL
are	NULL
required	NULL
for	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Assuming	NULL
that	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
transfected	NULL
Z	NULL
may	NULL
activate	NULL
Rp	NULL
in	NULL
latently	NULL
infected	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
combination	NULL
of	NULL
Z	NULL
and	NULL
R	NULL
then	NULL
leads	NULL
to	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transfected	NULL
R	NULL
may	NULL
be	NULL
incapable	NULL
of	NULL
activating	NULL
Zp	NULL
within	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
Z	NULL
and	NULL
R	NULL
upon	NULL
Zp	NULL
and	NULL
Rp	NULL
transcription	NULL
have	NULL
not	NULL
been	NULL
carefully	NULL
studied	NULL
except	NULL
in	NULL
transient	NULL
reporter	NULL
assays	NULL
.	NULL

In	NULL
these	NULL
types	NULL
of	NULL
experiments	NULL
,	NULL
Z	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
its	NULL
own	NULL
promoter	NULL
(	NULL
Zp	NULL
)	NULL
(	NULL
24	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
R	NULL
promoter	NULL
(	NULL
Rp	NULL
)	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
R	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
Rp	NULL
at	NULL
a	NULL
low	NULL
level	NULL
through	NULL
an	NULL
apparently	NULL
non-binding	NULL
mechanism	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
R	NULL
on	NULL
Zp	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
R	NULL
IE	NULL
protein	NULL
is	NULL
sufficient	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
an	NULL
epithelial	NULL
cell-specific	NULL
manner	NULL
.	NULL

This	NULL
ability	NULL
of	NULL
R	NULL
to	NULL
induce	NULL
lytic	NULL
viral	NULL
infection	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
lymphoid	NULL
cells	NULL
,	NULL
correlates	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
Zp	NULL
and	NULL
Rp	NULL
expression	NULL
from	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
only	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
of	NULL
plasmid-based	NULL
reporter	NULL
assays	NULL
,	NULL
transfected	NULL
Z	NULL
primarily	NULL
activates	NULL
Rp	NULL
in	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
,	NULL
rather	NULL
than	NULL
Zp	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
the	NULL
major	NULL
site	NULL
of	NULL
lytic	NULL
EBV	NULL
infection	NULL
in	NULL
vivo	NULL
)	NULL
,	NULL
cellular	NULL
transcription	NULL
factors	NULL
which	NULL
activate	NULL
Rp	NULL
may	NULL
initiate	NULL
the	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Lines	NULL
.	NULL

P3HR1	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
Akata	NULL
(	NULL
7	NULL
)	NULL
are	NULL
EBV-positive	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

SFC4	NULL
and	NULL
CB/95	NULL
are	NULL
human	NULL
B-cell	NULL
lines	NULL
immortalized	NULL
with	NULL
EBV	NULL
.	NULL

NPC-KT	NULL
is	NULL
an	NULL
EBV-positive	NULL
epithelial	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
the	NULL
fusion	NULL
of	NULL
a	NULL
human	NULL
adenoidal	NULL
epithelial	NULL
cell	NULL
line	NULL
and	NULL
a	NULL
primary	NULL
EBV-positive	NULL
nasopharyngeal	NULL
carcinoma	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
epithelial	NULL
D98/HE-R-1	NULL
cell	NULL
line	NULL
was	NULL
formed	NULL
by	NULL
fusion	NULL
of	NULL
a	NULL
HeLa	NULL
cell	NULL
subclone	NULL
(	NULL
D98	NULL
)	NULL
with	NULL
the	NULL
EBV-positive	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
P3HR/1	NULL
(	NULL
28	NULL
)	NULL
.	NULL

All	NULL
lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Epithelial	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
H	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

EBV	NULL
Plasmids	NULL
.	NULL

The	NULL
BMLF1	NULL
promoter	NULL
plasmid	NULL
contains	NULL
the	NULL
early	NULL
EBV	NULL
promoter	NULL
sequences	NULL
from	NULL
-331	NULL
to	NULL
+1	NULL
linked	NULL
to	NULL
the	NULL
Abbreviations	NULL
:	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
Z	NULL
,	NULL
BZLF1	NULL
gene	NULL
product	NULL
;	NULL
R	NULL
,	NULL
BRLF1	NULL
gene	NULL
product	NULL
;	NULL
Zp	NULL
,	NULL
BZLF1	NULL
promoter	NULL
;	NULL
Rp	NULL
,	NULL
BRLF1	NULL
promoter	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
IE	NULL
,	NULL
immediate-early	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
,	NULL
IUdR	NULL
,	NULL
io-dodeoxyuridine	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Microbiology	NULL
:	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

-p	NULL
o	NULL
--	NULL
Z	NULL
(	NULL
863	NULL
bp	NULL
)	NULL
R	NULL
and	NULL
Z	NULL
(	NULL
3837	NULL
bp	NULL
)	NULL
.	NULL

-=yy	NULL
R	NULL
and	NULL
Z	NULL
(	NULL
2897	NULL
bp	NULL
)	NULL
w—w	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
two	NULL
promoters	NULL
driving	NULL
Z	NULL
and	NULL
R	NULL
transcription	NULL
(	NULL
Zp	NULL
and	NULL
Rp	NULL
)	NULL
is	NULL
shown	NULL
below	NULL
the	NULL
genomic	NULL
map	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
messages	NULL
arising	NULL
from	NULL
these	NULL
promoters	NULL
is	NULL
shown	NULL
.	NULL

heterologous	NULL
reporter	NULL
gene	NULL
,	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
,	NULL
in	NULL
the	NULL
pCAT3M	NULL
vector	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
CMV-Z	NULL
plasmid	NULL
has	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
in	NULL
the	NULL
pHD1013	NULL
vector	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
two	NULL
BRLF1	NULL
expression	NULL
vectors	NULL
,	NULL
one	NULL
containing	NULL
the	NULL
BRLF1	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
CMV	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
and	NULL
another	NULL
containing	NULL
the	NULL
BRLF1	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
have	NULL
been	NULL
described	NULL
.	NULL

The	NULL
plasmid	NULL
pRZSphHind	NULL
contains	NULL
the	NULL
Hin-dIlI-SphI	NULL
fragment	NULL
(	NULL
spanning	NULL
the	NULL
EBV	NULL
sequences	NULL
from	NULL
-235	NULL
to	NULL
+115	NULL
relative	NULL
to	NULL
the	NULL
BZLF1	NULL
mRNA	NULL
start	NULL
site	NULL
)	NULL
inserted	NULL
into	NULL
the	NULL
HinclI	NULL
site	NULL
of	NULL
the	NULL
pBS	NULL
*+	NULL
plasmid	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
a	NULL
riboprobe	NULL
for	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

DNA	NULL
Transfection	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
purified	NULL
through	NULL
either	NULL
Qiagen	NULL
columns	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
double-banded	NULL
cesium	NULL
chloride	NULL
.	NULL

DNA	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
cells	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
Zapper	NULL
electroporation	NULL
unit	NULL
(	NULL
Medical	NULL
Electronics	NULL
Shop	NULL
,	NULL
University	NULL
of	NULL
Wisconsin	NULL
)	NULL
at	NULL
1500	NULL
V	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Epithelial	NULL
cells	NULL
were	NULL
suspended	NULL
into	NULL
RPMI	NULL
1640	NULL
medium	NULL
before	NULL
electroporation	NULL
.	NULL

CAT	NULL
Assays	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
[	NULL
'*CJchloramphenicol	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
percent	NULL
acetylation	NULL
of	NULL
chloramphenicol	NULL
was	NULL
quantitated	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
followed	NULL
by	NULL
PhosphorImager	NULL
screening	NULL
or	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

Immunoblot	NULL
Analysis	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
EBV	NULL
Z	NULL
and	NULL
BMRF1	NULL
proteins	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
Z	NULL
monoclonal	NULL
antibody	NULL
BZ.1	NULL
(	NULL
diluted	NULL
1:50	NULL
)	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Alan	NULL
Rickinson	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
Medical	NULL
School	NULL
,	NULL
Birmingham	NULL
,	NULL
U.K.	NULL
)	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
Z	NULL
expression	NULL
and	NULL
the	NULL
monoclonal	NULL
antibody	NULL
9240	NULL
(	NULL
diluted	NULL
1:40	NULL
)	NULL
(	NULL
Capricorn	NULL
)	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
induction	NULL
of	NULL
BMRF1	NULL
(	NULL
early	NULL
antigen-diffuse	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
visualized	NULL
by	NULL
the	NULL
chemiluminescence	NULL
method	NULL
after	NULL
immunoblotting	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

EBV	NULL
Termini	NULL
Analysis	NULL
.	NULL

Latently	NULL
infected	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
pHD1013	NULL
vector	NULL
DNA	NULL
,	NULL
the	NULL
BZLF1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
.	NULL

Total	NULL
cellular	NULL
DNA	NULL
was	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
cut	NULL
with	NULL
BamHI	NULL
,	NULL
run	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
*P-labeled	NULL
riboprobe	NULL
spanning	NULL
the	NULL
EBV	NULL
sequences	NULL
in	NULL
the	NULL
1.9-kb	NULL
Xhol	NULL
fragment	NULL
as	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

RNase	NULL
Protection	NULL
Assays	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
Trizol	NULL
reagent	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
the	NULL
pHD1013	NULL
vector	NULL
,	NULL
the	NULL
BZLFI1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
20	NULL
h	NULL
after	NULL
treatment	NULL
of	NULL
NPC-KT	NULL
cells	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
iododeoxyuridine	NULL
(	NULL
IUdR	NULL
)	NULL
(	NULL
75	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
4	NULL
h	NULL
after	NULL
treatment	NULL
of	NULL
Akata	NULL
cells	NULL
with	NULL
anti-human	NULL
IgG	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

RNase	NULL
protection	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
plasmid	NULL
pRZSphHind	NULL
was	NULL
cut	NULL
with	NULL
Dral	NULL
(	NULL
-34	NULL
relative	NULL
to	NULL
the	NULL
BZLF1	NULL
mRNA	NULL
start	NULL
site	NULL
)	NULL
and	NULL
transcribed	NULL
using	NULL
T3	NULL
RNA	NULL
polymerase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
P-labeled	NULL
UTP	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
9195	NULL
to	NULL
yield	NULL
a	NULL
156-bp	NULL
antisense	NULL
riboprobe	NULL
spanning	NULL
the	NULL
Zp	NULL
initiation	NULL
site	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
15-20	NULL
pg	NULL
)	NULL
was	NULL
hybridized	NULL
with	NULL
20,000	NULL
cpm	NULL
of	NULL
riboprobe	NULL
at	NULL
50°C	NULL
for	NULL
16	NULL
h	NULL
and	NULL
then	NULL
digested	NULL
with	NULL
3	NULL
units	NULL
of	NULL
RNase	NULL
One	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h.	NULL
Samples	NULL
were	NULL
denatured	NULL
and	NULL
fragments	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
through	NULL
an	NULL
8	NULL
M	NULL
urea/polyacrylamide	NULL
gel	NULL
.	NULL

Hybridization	NULL
to	NULL
Zp-and	NULL
Rp-initiated	NULL
transcripts	NULL
yields	NULL
protected	NULL
species	NULL
of	NULL
115	NULL
and	NULL
148	NULL
bp	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
radiolabeled	NULL
actin	NULL
riboprobe	NULL
was	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
using	NULL
the	NULL
actin	NULL
control	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

RESULTS	NULL
R	NULL
Activates	NULL
Early	NULL
Gene	NULL
Expression	NULL
in	NULL
Epithelial	NULL
Cells	NULL
But	NULL
Not	NULL
Lymphoid	NULL
Cells	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
ability	NULL
of	NULL
R	NULL
versus	NULL
Z	NULL
to	NULL
induce	NULL
lytic	NULL
viral	NULL
infection	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
R	NULL
or	NULL
Z	NULL
gene	NULL
products	NULL
(	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
strong	NULL
constitutive	NULL
promoter	NULL
)	NULL
into	NULL
various	NULL
types	NULL
of	NULL
latently	NULL
infected	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
early	NULL
viral	NULL
protein	NULL
,	NULL
BMRF1	NULL
(	NULL
early	NULL
antigen-diffuse	NULL
)	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
the	NULL
Raji	NULL
EBV-infected	NULL
Burkitt	NULL
lymphocyte	NULL
line	NULL
in	NULL
Fig	NULL
.	NULL

2a	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
Z	NULL
gene	NULL
product	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
induced	NULL
early	NULL
antigen	NULL
expression	NULL
.	NULL

In	NULL
Burkitt	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
R	NULL
protein	NULL
did	NULL
not	NULL
activate	NULL
early	NULL
antigen	NULL
expression	NULL
.	NULL

Likewise	NULL
,	NULL
as	NULL
shown	NULL
for	NULL
CB/95	NULL
,	NULL
a	NULL
primary	NULL
B-cell	NULL
line	NULL
immortalized	NULL
by	NULL
EBV	NULL
a	NULL
)	NULL
_	NULL
RAJ	NULL
!	NULL

b	NULL
)	NULL
p	NULL
=z	NULL
__	NULL
-__-	NULL
3	NULL
o-	NULL
--	NULL
-I	NULL
5	NULL
E	NULL
C	NULL
5	NULL
C	NULL
E	NULL
ub	NULL
mad	NULL
«	NULL
d	NULL
wad	NULL
$	NULL
|	NULL
®	NULL
3	NULL
d	NULL
5	NULL
+	NULL
EAD	NULL
<	NULL
-	NULL
EAD	NULL
4-2	NULL
4-Z	NULL
©	NULL
)	NULL
-	NULL
weo-Kt	NULL
9	NULL
)	NULL
pes/HE-R-1	NULL
F	NULL
--	NULL
-	NULL
|	NULL
5	NULL
E	NULL
E	NULL
5	NULL
E	NULL
E	NULL
aad	NULL
wd	NULL
wad	NULL
wad	NULL
$	NULL
|	NULL
&	NULL
3	NULL
|	NULL
®	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Five	NULL
micrograms	NULL
of	NULL
pHD1013	NULL
vector	NULL
DNA	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
E.	NULL
S.	NULL
Huang	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
)	NULL
,	NULL
the	NULL
BZLFI1	NULL
expression	NULL
plasmid	NULL
(	NULL
containing	NULL
the	NULL
BZLF1	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
CMV	NULL
IE	NULL
promoter	NULL
)	NULL
,	NULL
or	NULL
the	NULL
BRLFI	NULL
expression	NULL
construct	NULL
(	NULL
containing	NULL
the	NULL
BRLF1	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
IE	NULL
promoter	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
cells	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
used	NULL
included	NULL
a	NULL
latently	NULL
infected	NULL
Burkitt	NULL
B-cell	NULL
line	NULL
(	NULL
Raji	NULL
)	NULL
(	NULL
4	NULL
)	NULL
,	NULL
a	NULL
primary	NULL
B	NULL
cell	NULL
line	NULL
immortalized	NULL
with	NULL
EBV	NULL
(	NULL
CB/95	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
two	NULL
latently	NULL
infected	NULL
epithelial	NULL
cell	NULL
lines	NULL
,	NULL
NPC-KT	NULL
(	NULL
C	NULL
)	NULL
and	NULL
D98/HE-R-1	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
monoclonal	NULL
antibody	NULL
BZ.1	NULL
(	NULL
diluted	NULL
1:50	NULL
)	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Alan	NULL
Rickinson	NULL
)	NULL
to	NULL
detect	NULL
the	NULL
presence	NULL
of	NULL
Z	NULL
,	NULL
and	NULL
the	NULL
monoclonal	NULL
antibody	NULL
9240	NULL
(	NULL
diluted	NULL
1:40	NULL
)	NULL
(	NULL
Capricorn	NULL
)	NULL
to	NULL
detect	NULL
the	NULL
expression	NULL
of	NULL
early	NULL
antigen-diffuse	NULL
(	NULL
EAD	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
as	NULL
shown	NULL
in	NULL
4	NULL
and	NULL
B	NULL
were	NULL
obtained	NULL
with	NULL
another	NULL
Burkitt	NULL
cell	NULL
line	NULL
,	NULL
P3HR1	NULL
,	NULL
and	NULL
another	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
SFC4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

9196	NULL
Microbiology	NULL
:	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
Z	NULL
,	NULL
but	NULL
not	NULL
R	NULL
,	NULL
induced	NULL
early	NULL
antigen	NULL
expression	NULL
,	NULL
although	NULL
in	NULL
these	NULL
cells	NULL
Z	NULL
was	NULL
considerably	NULL
less	NULL
efficient	NULL
in	NULL
disrupting	NULL
viral	NULL
latency	NULL
than	NULL
in	NULL
the	NULL
Burkitt	NULL
lines	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
either	NULL
R	NULL
or	NULL
Z	NULL
induced	NULL
early	NULL
viral	NULL
protein	NULL
expression	NULL
in	NULL
two	NULL
different	NULL
EBV-infected	NULL
epithelial	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
lytic	NULL
viral	NULL
infection	NULL
likely	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
Z	NULL
,	NULL
as	NULL
well	NULL
as	NULL
R	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
transfected	NULL
R	NULL
to	NULL
induce	NULL
Z	NULL
expression	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
from	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
)	NULL
was	NULL
assessed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
to	NULL
the	NULL
Z	NULL
protein	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
¢	NULL
and	NULL
d	NULL
,	NULL
epithelial	NULL
cells	NULL
transfected	NULL
with	NULL
R	NULL
also	NULL
expressed	NULL
the	NULL
IE	NULL
protein	NULL
Z	NULL
,	NULL
indicating	NULL
that	NULL
R	NULL
can	NULL
activate	NULL
Z	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
a	NULL
BRLF1	NULL
expression	NULL
vector	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
expression	NULL
of	NULL
R	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
lytic	NULL
viral	NULL
cascade	NULL
in	NULL
epithelial	NULL
cells	NULL
but	NULL
not	NULL
lymphoid	NULL
cells	NULL
.	NULL

R	NULL
Induces	NULL
Lytic	NULL
EBV	NULL
Replication	NULL
in	NULL
Epithelial	NULL
Cells	NULL
.	NULL

The	NULL
previous	NULL
results	NULL
indicate	NULL
that	NULL
R	NULL
can	NULL
activate	NULL
expression	NULL
of	NULL
at	NULL
least	NULL
two	NULL
lytic	NULL
EBV	NULL
genes	NULL
(	NULL
BZLF1	NULL
and	NULL
BMRF1	NULL
)	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
many	NULL
different	NULL
EBV	NULL
genes	NULL
are	NULL
required	NULL
for	NULL
lytic	NULL
replication	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
early	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
R	NULL
in	NULL
epithelial	NULL
cells	NULL
might	NULL
be	NULL
abortive	NULL
and	NULL
not	NULL
support	NULL
successful	NULL
viral	NULL
replication	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
ability	NULL
of	NULL
Z	NULL
versus	NULL
R	NULL
to	NULL
induce	NULL
lytic	NULL
viral	NULL
replication	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
Southern	NULL
blot	NULL
analyses	NULL
to	NULL
distinguish	NULL
latent	NULL
(	NULL
episomal	NULL
)	NULL
versus	NULL
lytic	NULL
(	NULL
linear	NULL
)	NULL
EBV	NULL
genomes	NULL
as	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
expression	NULL
of	NULL
Z	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
resulted	NULL
in	NULL
conversion	NULL
of	NULL
the	NULL
virus	NULL
from	NULL
the	NULL
episomal	NULL
to	NULL
the	NULL
linear	NULL
form	NULL
in	NULL
both	NULL
lymphoid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
epithelial	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
immunoblot	NULL
analysis	NULL
,	NULL
expression	NULL
of	NULL
R	NULL
also	NULL
induced	NULL
lytic	NULL
replication	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
R	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
full	NULL
lytic	NULL
infection	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
not	NULL
simply	NULL
abortive	NULL
expression	NULL
of	NULL
viral	NULL
early	NULL
proteins	NULL
.	NULL

R	NULL
Induces	NULL
Zp	NULL
and	NULL
Rp	NULL
Transcription	NULL
in	NULL
Epithelial	NULL
Cells	NULL
But	NULL
Not	NULL
Lymphoid	NULL
Cells	NULL
.	NULL

In	NULL
a	NULL
recently	NULL
proposed	NULL
model	NULL
for	NULL
EBV	NULL
2	NULL
)	NULL
wpo-KtT	NULL
©	NULL
)	NULL
nes/HE-R-1	NULL
r	NULL
‘	NULL
g—	NULL
‘	NULL
——|	NULL
U.	NULL
AHE	NULL
$	NULL
BZLF1	NULL
BRLF1	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Latently	NULL
infected	NULL
NPC-KT	NULL
(	NULL
4	NULL
)	NULL
and	NULL
D98/HE-R-1	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pHD1013	NULL
vector	NULL
DNA	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
BZLF1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
BRLFI1	NULL
vector	NULL
DNA	NULL
.	NULL

The	NULL
cellular	NULL
DNA	NULL
was	NULL
isolated	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cut	NULL
with	NULL
the	NULL
restriction	NULL
enzyme	NULL
BamHI	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Southern	NULL
blot	NULL
using	NULL
a	NULL
-labeled	NULL
riboprobe	NULL
spanning	NULL
the	NULL
1.9-kb	NULL
XhoI	NULL
sequence	NULL
of	NULL
EBV	NULL
.	NULL

This	NULL
assay	NULL
(	NULL
32	NULL
)	NULL
distinguishes	NULL
between	NULL
fused	NULL
versus	NULL
unfused	NULL
viral	NULL
termini	NULL
.	NULL

The	NULL
latent	NULL
(	NULL
episomal	NULL
)	NULL
virus	NULL
contains	NULL
only	NULL
fused	NULL
termini	NULL
,	NULL
whereas	NULL
lytic	NULL
replication	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
fused	NULL
termini	NULL
(	NULL
due	NULL
to	NULL
replicative	NULL
intermediates	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
appearance	NULL
of	NULL
unfused	NULL
termini	NULL
(	NULL
due	NULL
to	NULL
the	NULL
replicated	NULL
linear	NULL
form	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
reactivation	NULL
(	NULL
23	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
Zp	NULL
transcription	NULL
by	NULL
cellular	NULL
factors	NULL
is	NULL
the	NULL
initial	NULL
event	NULL
leading	NULL
to	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
the	NULL
Z	NULL
protein	NULL
then	NULL
activates	NULL
Rp	NULL
,	NULL
as	NULL
well	NULL
as	NULL
further	NULL
activating	NULL
Zp	NULL
.	NULL

The	NULL
combined	NULL
transactivator	NULL
functions	NULL
of	NULL
Z	NULL
and	NULL
R	NULL
then	NULL
lead	NULL
to	NULL
an	NULL
irreversible	NULL
activation	NULL
of	NULL
the	NULL
lytic	NULL
cascade	NULL
.	NULL

However	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
transfected	NULL
Z	NULL
and	NULL
R	NULL
upon	NULL
Zp	NULL
and	NULL
Rp	NULL
expression	NULL
within	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
have	NULL
not	NULL
been	NULL
well	NULL
studied	NULL
.	NULL

Using	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
transfected	NULL
R	NULL
and	NULL
Z	NULL
upon	NULL
Zp	NULL
and	NULL
Rp	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
1.0-kb	NULL
BZLF	NULL
!	NULL

1	NULL
RNA	NULL
(	NULL
arising	NULL
from	NULL
Zp	NULL
)	NULL
and	NULL
2.8-kb	NULL
BRLFI	NULL
plus	NULL
BZLF1	NULL
RNA	NULL
(	NULL
arising	NULL
from	NULL
Rp	NULL
)	NULL
were	NULL
detected	NULL
using	NULL
an	NULL
RNA	NULL
probe	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

42	NULL
.	NULL

Disruption	NULL
of	NULL
viral	NULL
latency	NULL
induced	NULL
by	NULL
either	NULL
cross-linking	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
Akata	NULL
cells	NULL
)	NULL
or	NULL
PMA/IUdR	NULL
treatment	NULL
(	NULL
D98	NULL
and	NULL
NPC-KT	NULL
cells	NULL
)	NULL
activated	NULL
Zp	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Rp	NULL
,	NULL
expression	NULL
in	NULL
each	NULL
cell	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
PMA	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
either	NULL
Raji	NULL
or	NULL
Akata	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
immunoglobulin	NULL
cross-linking	NULL
and	NULL
PMA	NULL
,	NULL
transfected	NULL
Z	NULL
primarily	NULL
activated	NULL
Rp	NULL
(	NULL
with	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
Zp	NULL
transcription	NULL
observed	NULL
)	NULL
in	NULL
both	NULL
the	NULL
Raji	NULL
B-cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

4c	NULL
)	NULL
and	NULL
the	NULL
epithelial	NULL
D98/HE-R-1	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

40	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
in	NULL
conflict	NULL
with	NULL
the	NULL
results	NULL
of	NULL
plasmid-based	NULL
reporter	NULL
gene	NULL
assays	NULL
,	NULL
in	NULL
which	NULL
Z	NULL
can	NULL
activate	NULL
its	NULL
own	NULL
promoter	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Transfected	NULL
R	NULL
did	NULL
not	NULL
activate	NULL
either	NULL
Zp	NULL
or	NULL
Rp	NULL
in	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

4¢c	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
R	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
seen	NULL
in	NULL
Burkitt	NULL
cells	NULL
,	NULL
R	NULL
activated	NULL
both	NULL
Zp	NULL
and	NULL
Rp	NULL
in	NULL
the	NULL
epithelial	NULL
D98/HE-R-1	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

40	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
epithelial	NULL
NPC-KT	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
transfected	NULL
R	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
lymphoid	NULL
cells	NULL
,	NULL
correlates	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
Zp	NULL
and	NULL
Rp	NULL
transcription	NULL
from	NULL
the	NULL
endogenous	NULL
viral	NULL
genome	NULL
in	NULL
an	NULL
epithelial	NULL
cell-specific	NULL
manner	NULL
.	NULL

The	NULL
R	NULL
Transactivator	NULL
Function	NULL
Is	NULL
Not	NULL
Cell	NULL
Type-Specific	NULL
in	NULL
Plasmid-Based	NULL
Reporter	NULL
Assays	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
R	NULL
transactivator	NULL
function	NULL
is	NULL
impaired	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
plasmid-based	NULL
reporter	NULL
gene	NULL
assays	NULL
using	NULL
an	NULL
early	NULL
EBV	NULL
promoter	NULL
construct	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
directly	NULL
bound	NULL
and	NULL
transcriptionally	NULL
activated	NULL
by	NULL
R	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
transcriptional	NULL
activator	NULL
function	NULL
of	NULL
transfected	NULL
R	NULL
in	NULL
plasmid-based	NULL
assays	NULL
is	NULL
similar	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
epithelial	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
transfected	NULL
R	NULL
to	NULL
activate	NULL
viral	NULL
replication	NULL
in	NULL
B	NULL
cells	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
essential	NULL
trans-acting	NULL
factor	NULL
required	NULL
for	NULL
R	NULL
transactivator	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
This	NULL
report	NULL
demonstrates	NULL
that	NULL
the	NULL
EBV	NULL
IE	NULL
protein	NULL
,	NULL
R	NULL
,	NULL
can	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
an	NULL
epithelial	NULL
cell-specific	NULL
fashion	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
EBV	NULL
reactivation	NULL
have	NULL
examined	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
viral	NULL
latency	NULL
is	NULL
disrupted	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
have	NULL
identified	NULL
the	NULL
Z	NULL
IE	NULL
protein	NULL
as	NULL
the	NULL
critical	NULL
initiator	NULL
of	NULL
this	NULL
process	NULL
.	NULL

However	NULL
,	NULL
since	NULL
lytic	NULL
EBV	NULL
replication	NULL
in	NULL
vivo	NULL
occurs	NULL
primarily	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
rather	NULL
than	NULL
B	NULL
cells	NULL
,	NULL
induction	NULL
of	NULL
lytic	NULL
viral	NULL
replication	NULL
by	NULL
R	NULL
may	NULL
be	NULL
an	NULL
equally	NULL
important	NULL
mechanism	NULL
for	NULL
disrupting	NULL
viral	NULL
latency	NULL
in	NULL
the	NULL
human	NULL
host	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
transfected	NULL
R	NULL
to	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
B	NULL
cells	NULL
,	NULL
correlates	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
Zp	NULL
and	NULL
Rp	NULL
promoters	NULL
only	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

R	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
which	NULL
binds	NULL
to	NULL
specific	NULL
G+C-rich	NULL
motifs	NULL
present	NULL
in	NULL
many	NULL
early	NULL
EBV	NULL
promoters	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
R	NULL
activates	NULL
expression	NULL
of	NULL
both	NULL
Zp	NULL
and	NULL
Rp	NULL
in	NULL
the	NULL
endogenous	NULL
genome	NULL
is	NULL
somewhat	NULL
surprising	NULL
,	NULL
given	NULL
that	NULL
neither	NULL
of	NULL
these	NULL
promoters	NULL
is	NULL
thought	NULL
to	NULL
contain	NULL
R	NULL
binding	NULL
sites	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
(	NULL
and	NULL
others	NULL
)	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
R	NULL
binding	NULL
sites	NULL
can	NULL
function	NULL
from	NULL
a	NULL
distance	NULL
as	NULL
enhancer	NULL
elements	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
22	NULL
)	NULL
,	NULL
and	NULL
more	NULL
than	NULL
300	NULL
putative	NULL
R	NULL
binding	NULL
Microbiology	NULL
:	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
9197	NULL
a	NULL
)	NULL
inant	NULL
Drai	NULL
c	NULL
)	NULL
__RAJi	NULL
a	NULL
por-	NULL
ean	NULL
Zp	NULL
<	NULL
--	NULL
-	NULL
from	NULL
Rp	NULL
§	NULL
tad	NULL
wl	NULL
N	NULL
-	NULL
C	NULL
Hindill	NULL
Drai	NULL
>	NULL
m	NULL
_	NULL
®	NULL
T3	NULL
[	NULL
J	NULL
|	NULL
f	NULL
$	NULL
Undlgoctod	NULL
Protected	NULL
*-	NULL
Rp	NULL
fragment	NULL
Probe	NULL
E	NULL
i	NULL
156	NULL
bp	NULL
Zp	NULL
(	NULL
115	NULL
bp	NULL
]	NULL
zp	NULL
Rp	NULL
|	NULL
|	NULL
148	NULL
bp	NULL
Z	NULL
Vector	NULL
-	NULL
80	NULL
bp	NULL
e	NULL
t	NULL
ﬂ	NULL
MB	NULL
<	NULL
-	NULL
Actin	NULL
D	NULL
)	NULL
_	NULL
Akata	NULL
_	NULL
NPC	NULL
D98/HE-R-1	NULL
d	NULL
)	NULL
Des/HE-R-1	NULL
IgG	NULL
TPA+IUdR	NULL
-	NULL
TPA+IUdR	NULL
5	NULL
E	NULL
&	NULL
F	NULL
H	NULL
D	NULL
1	NULL
§	NULL
pac	NULL
El	NULL
Commanments	NULL
$	NULL
B	NULL
&	NULL
i	NULL
Undigested	NULL
gested	NULL
#	NULL
<	NULL
e	NULL
(	NULL
+	NULL
Rp	NULL
®	NULL
a	NULL
-	NULL
:	NULL
,	NULL
]	NULL
z	NULL
#	NULL
B	NULL
|	NULL
:	NULL
o	NULL
@	NULL
w	NULL
--	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

(	NULL
a	NULL
)	NULL
RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
single-strand	NULL
*°P-labeled	NULL
riboprobe	NULL
.	NULL

Hybridization	NULL
of	NULL
the	NULL
probe	NULL
to	NULL
Zp-	NULL
and	NULL
Rp-derived	NULL
mRNA	NULL
results	NULL
in	NULL
protected	NULL
fragments	NULL
of	NULL
115	NULL
and	NULL
148	NULL
bp	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
transfected	NULL
BZLF1	NULL
vector	NULL
yields	NULL
an	NULL
80-bp	NULL
protected	NULL
fragment	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
Akata	NULL
Burkitt	NULL
cells	NULL
[	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
anti-human	NULL
IgG	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
]	NULL
,	NULL
NPC-KT	NULL
cells	NULL
[	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
TPA	NULL
;	NULL
20	NULL
ng/ml	NULL
)	NULL
and	NULL
IUdR	NULL
(	NULL
75	NULL
ug/ml	NULL
)	NULL
for	NULL
20	NULL
h	NULL
}	NULL
,	NULL
and	NULL
D98/HE-R-1	NULL
cells	NULL
(	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
IUdR	NULL
for	NULL
20	NULL
hours	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
*°P-labeled	NULL
riboprobe	NULL
,	NULL
digested	NULL
with	NULL
RNase	NULL
(	NULL
Promega	NULL
RNase	NULL
protection	NULL
assay	NULL
system	NULL
)	NULL
,	NULL
denatured	NULL
,	NULL
and	NULL
run	NULL
on	NULL
a	NULL
6	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
expected	NULL
size	NULL
of	NULL
the	NULL
Zp-	NULL
and	NULL
Rp-derived	NULL
protected	NULL
fragments	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pHD1013	NULL
vector	NULL
DNA	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
BZLF1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
DNA	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
examined	NULL
in	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

The	NULL
corresponding	NULL
actin	NULL
mRNA	NULL
for	NULL
each	NULL
condition	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
panel	NULL
below	NULL
.	NULL

(	NULL
d	NULL
)	NULL
D98/HE-R-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
vector	NULL
DNA	NULL
,	NULL
the	NULL
BZLF1	NULL
expression	NULL
vector	NULL
,	NULL
or	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
and	NULL
processed	NULL
for	NULL
RNase	NULL
protection	NULL
assays	NULL
as	NULL
described	NULL
above	NULL
.	NULL

sites	NULL
have	NULL
been	NULL
located	NULL
in	NULL
the	NULL
EBV	NULL
genome	NULL
(	NULL
18	NULL
)	NULL
.	NULL

It	NULL
thus	NULL
remains	NULL
possible	NULL
that	NULL
distant	NULL
R	NULL
binding	NULL
sites	NULL
(	NULL
not	NULL
contained	NULL
within	NULL
the	NULL
previously	NULL
studied	NULL
Zp	NULL
and	NULL
Rp	NULL
reporter	NULL
constructs	NULL
)	NULL
mediate	NULL
R-induced	NULL
activation	NULL
of	NULL
Zp	NULL
and	NULL
Rp	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

Assuming	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
then	NULL
the	NULL
Rp	NULL
and	NULL
Zp	NULL
promoters	NULL
are	NULL
presumably	NULL
less	NULL
accessible	NULL
to	NULL
direct	NULL
binding	NULL
by	NULL
R	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Cell-specific	NULL
differences	NULL
in	NULL
the	NULL
methylation	NULL
state	NULL
of	NULL
the	NULL
Zp	NULL
and	NULL
Rp	NULL
promoters	NULL
,	NULL
or	NULL
differences	NULL
in	NULL
the	NULL
chromatin	NULL
configuration	NULL
around	NULL
these	NULL
promoters	NULL
,	NULL
might	NULL
exclude	NULL
R	NULL
binding	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
while	NULL
allowing	NULL
such	NULL
binding	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
suggested	NULL
(	NULL
26	NULL
)	NULL
,	NULL
R	NULL
may	NULL
activate	NULL
certain	NULL
promoters	NULL
through	NULL
a	NULL
nonbinding	NULL
mechanism	NULL
.	NULL

If	NULL
the	NULL
R-induced	NULL
activation	NULL
of	NULL
Zp	NULL
and	NULL
Rp	NULL
is	NULL
mediated	NULL
through	NULL
this	NULL
novel	NULL
mechanism	NULL
,	NULL
then	NULL
the	NULL
trans-acting	NULL
cellular	NULL
factors	NULL
required	NULL
for	NULL
this	NULL
process	NULL
may	NULL
be	NULL
more	NULL
available	NULL
in	NULL
epithelial	NULL
cells	NULL
than	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
domains	NULL
of	NULL
R	NULL
essential	NULL
for	NULL
transactivator	NULL
function	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
cell-type	NULL
dependent	NULL
(	NULL
33	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
R-induced	NULL
transactivation	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
different	NULL
mechanisms	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Another	NULL
group	NULL
has	NULL
previously	NULL
reported	NULL
that	NULL
R	NULL
expressed	NULL
in	NULL
vaccinia	NULL
virus	NULL
can	NULL
activate	NULL
early	NULL
gene	NULL
expression	NULL
in	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
Burkitt	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
group	NULL
did	NULL
not	NULL
define	NULL
whether	NULL
the	NULL
R	NULL
vaccinia	NULL
virus	NULL
induced	NULL
abortive	NULL
lytic	NULL
infection	NULL
(	NULL
limited	NULL
to	NULL
early	NULL
gene	NULL
expression	NULL
)	NULL
or	NULL
progressed	NULL
to	NULL
full	NULL
viral	NULL
replication	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
here	NULL
clearly	NULL
indicate	NULL
that	NULL
transfected	NULL
R	NULL
alone	NULL
(	NULL
in	NULL
contrast	NULL
to	NULL
Z	NULL
)	NULL
can	NULL
not	NULL
disrupt	NULL
viral	NULL
latency	NULL
in	NULL
lymphoblastoid	NULL
cells	NULL
.	NULL

It	NULL
remains	NULL
possible	NULL
that	NULL
a	NULL
vaccinia	NULL
virus-encoded	NULL
protein	NULL
allows	NULL
R	NULL
to	NULL
perform	NULL
this	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
that	NULL
the	NULL
Z	NULL
gene	NULL
product	NULL
can	NULL
activate	NULL
expression	NULL
of	NULL
Zp	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
results	NULL
of	NULL
such	NULL
assays	NULL
,	NULL
a	NULL
model	NULL
for	NULL
EBV	NULL
reactivation	NULL
has	NULL
been	NULL
proposed	NULL
(	NULL
23	NULL
)	NULL
in	NULL
which	NULL
Zp	NULL
is	NULL
initially	NULL
activated	NULL
by	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
followed	NULL
by	NULL
autoactivation	NULL
of	NULL
Zp	NULL
by	NULL
its	NULL
own	NULL
gene	NULL
product	NULL
,	NULL
and	NULL
Z-induced	NULL
activation	NULL
of	NULL
Rp	NULL
.	NULL

The	NULL
precise	NULL
cellular	NULL
transcription	NULL
factors	NULL
initially	NULL
activating	NULL
Zp	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
defined	NULL
,	NULL
although	NULL
both	NULL
CREB	NULL
and	NULL
API	NULL
have	NULL
been	NULL
suggested	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
results	NULL
here	NULL
indicate	NULL
that	NULL
transfected	NULL
Z	NULL
primarily	NULL
activates	NULL
Rp	NULL
,	NULL
rather	NULL
than	NULL
Zp	NULL
,	NULL
in	NULL
the	NULL
endogenous	NULL
genome	NULL
.	NULL

Another	NULL
group	NULL
has	NULL
recently	NULL
reported	NULL
a	NULL
similar	NULL
result	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
results	NULL
of	NULL
transient	NULL
plasmid-based	NULL
assays	NULL
may	NULL
not	NULL
reflect	NULL
the	NULL
sequence	NULL
of	NULL
events	NULL
in	NULL
the	NULL
actual	NULL
genome	NULL
.	NULL

Instead	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
(	NULL
model	NULL
1	NULL
)	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
activation	NULL
of	NULL
Zp	NULL
by	NULL
cellular	NULL
transcription	NULL
factors	NULL
leads	NULL
to	NULL
subsequent	NULL
activation	NULL
of	NULL
Rp	NULL
,	NULL
rather	NULL
than	NULL
Zp	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
the	NULL
Z	NULL
and	NULL
R	NULL
transcription	NULL
factors	NULL
would	NULL
then	NULL
lead	NULL
to	NULL
maximal	NULL
induction	NULL
of	NULL
early	NULL
EBV	NULL
promoters	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
21	NULL
)	NULL
.	NULL

From	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
,	NULL
we	NULL
now	NULL
propose	NULL
an	NULL
additional	NULL
mechanism	NULL
for	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

This	NULL
pathway	NULL
would	NULL
be	NULL
initiated	NULL
by	NULL
cellular	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
activate	NULL
Rp	NULL
(	NULL
such	NULL
as	NULL
Zif268	NULL
and	NULL
Sp1	NULL
)	NULL
(	NULL
26	NULL
,	NULL
31	NULL
)	NULL
,	NULL
rather	NULL
than	NULL
Zp	NULL
.	NULL

The	NULL
resultant	NULL
R	NULL
protein	NULL
would	NULL
then	NULL
lead	NULL
to	NULL
further	NULL
activation	NULL
of	NULL
9198	NULL
Microbiology	NULL
:	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

100	NULL
7	NULL
RAJ	NULL
D9	NULL
&	NULL
/HE-R-1	NULL
so	NULL
{	NULL
40	NULL
4	NULL
FOLD	NULL
ACTIVATION	NULL
VECTOR	NULL
BRLF1	NULL
VECTOR	NULL
BRLF1	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

D98/HE-R-1	NULL
and	NULL
Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
BMLF1	NULL
promoter	NULL
plasmid	NULL
(	NULL
containing	NULL
the	NULL
BMLF1	NULL
early	NULL
EBV	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
either	NULL
the	NULL
pHD1013	NULL
vector	NULL
or	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
average	NULL
fold	NULL
activation	NULL
after	NULL
co-transfection	NULL
with	NULL
the	NULL
BRLF1	NULL
expression	NULL
vector	NULL
versus	NULL
the	NULL
control	NULL
vector	NULL
is	NULL
shown	NULL
.	NULL

Rp	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Zp	NULL
.	NULL

As	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
R	NULL
and	NULL
Z	NULL
would	NULL
subsequently	NULL
induce	NULL
maximal	NULL
activation	NULL
of	NULL
early	NULL
viral	NULL
promoters	NULL
.	NULL

It	NULL
remains	NULL
possible	NULL
that	NULL
simultaneous	NULL
activation	NULL
of	NULL
Zp	NULL
and	NULL
Rp	NULL
occurs	NULL
in	NULL
some	NULL
circumstances	NULL
.	NULL

The	NULL
transmission	NULL
of	NULL
herpesviruses	NULL
from	NULL
host	NULL
to	NULL
host	NULL
requires	NULL
that	NULL
viral	NULL
latency	NULL
be	NULL
disrupted	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
here	NULL
a	NULL
novel	NULL
mechanism	NULL
for	NULL
disruption	NULL
of	NULL
EBV	NULL
latency	NULL
in	NULL
epithelial	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Given	NULL
the	NULL
rather	NULL
unusual	NULL
histories	NULL
of	NULL
our	NULL
two	NULL
EBV-infected	NULL
epithelial	NULL
cell	NULL
lines	NULL
(	NULL
both	NULL
being	NULL
derived	NULL
from	NULL
fusions	NULL
of	NULL
an	NULL
EBV-infected	NULL
cell	NULL
with	NULL
an	NULL
epithelial	NULL
cell	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
confirm	NULL
our	NULL
results	NULL
with	NULL
additional	NULL
studies	NULL
before	NULL
concluding	NULL
that	NULL
our	NULL
results	NULL
are	NULL
relevent	NULL
to	NULL
EBV	NULL
MODEL	NULL
1	NULL
MODEL	NULL
2	NULL
EPITHELIAL	NULL
CELLS	NULL
AND	NULL
B	NULL
CELLS	NULL
EPITHELIAL	NULL
CELLS	NULL
CREB/JUN	NULL
(	NULL
?	NULL
)	NULL

ZIF268	NULL
(	NULL
?	NULL
)	NULL

4	NULL
L	NULL
Zp	NULL
Rp	NULL
Ak	NULL
.	NULL
}	NULL

.	NULL

Zp	NULL
R	NULL
-*-	NULL
»	NULL
Rp	NULL
\../C	NULL
|	NULL
}	NULL
EARLY	NULL
EARLY	NULL
PROTEINS	NULL
PROTEINS	NULL
FiG	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Shown	NULL
is	NULL
a	NULL
schematic	NULL
representation	NULL
of	NULL
models	NULL
for	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Model	NULL
1	NULL
(	NULL
B	NULL
cells	NULL
and	NULL
epithelial	NULL
cells	NULL
)	NULL
:	NULL
Cellular	NULL
factors	NULL
initially	NULL
activate	NULL
Zp	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
production	NULL
of	NULL
Z	NULL
.	NULL

Z	NULL
subsequently	NULL
activates	NULL
Rp	NULL
,	NULL
leading	NULL
to	NULL
production	NULL
of	NULL
R.	NULL
Z	NULL
and	NULL
R	NULL
can	NULL
synergistically	NULL
activate	NULL
early	NULL
viral	NULL
promoters	NULL
leading	NULL
to	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Model	NULL
2	NULL
(	NULL
epithelial	NULL
cells	NULL
only	NULL
)	NULL
:	NULL
Cellular	NULL
factors	NULL
initially	NULL
activate	NULL
Rp	NULL
rather	NULL
than	NULL
Zp	NULL
.	NULL

The	NULL
R	NULL
protein	NULL
subsequently	NULL
activates	NULL
its	NULL
own	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
Zp	NULL
.	NULL

Z	NULL
and	NULL
R	NULL
then	NULL
synergistically	NULL
activate	NULL
early	NULL
viral	NULL
promoters	NULL
,	NULL
as	NULL
in	NULL
model	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
infected	NULL
epithelial	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Nevertheless	NULL
,	NULL
since	NULL
the	NULL
major	NULL
site	NULL
of	NULL
lytic	NULL
EBV	NULL
replication	NULL
in	NULL
the	NULL
human	NULL
host	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
within	NULL
epithelial	NULL
cells	NULL
rather	NULL
than	NULL
B	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
,	NULL
this	NULL
newly	NULL
recognized	NULL
pathway	NULL
for	NULL
viral	NULL
reactivation	NULL
may	NULL
in	NULL
fact	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
vivo	NULL
for	NULL
transmission	NULL
of	NULL
virus	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
specific	NULL
cellular	NULL
factors	NULL
that	NULL
disrupt	NULL
viral	NULL
latency	NULL
will	NULL
ultimately	NULL
be	NULL
required	NULL
for	NULL
a	NULL
full	NULL
understanding	NULL
of	NULL
this	NULL
key	NULL
aspect	NULL
of	NULL
herpesvirus	NULL
biology	NULL
.	NULL

Our	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
cellular	NULL
factors	NULL
that	NULL
activate	NULL
Rp	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Zp	NULL
,	NULL
may	NULL
mediate	NULL
disruption	NULL
of	NULL
viral	NULL
latency	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Joseph	NULL
Pagano	NULL
and	NULL
Albert	NULL
Baldwin	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
Rachel	NULL
Elizabeth	NULL
Edwards	NULL
for	NULL
help	NULL
with	NULL
the	NULL
viral	NULL
replication	NULL
assay	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
RO1CA58853	NULL
and	NULL
KO4CAO1711	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

1	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
&	NULL
Leibowitz	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Virology	NULL
,	NULL
eds	NULL
.	NULL

Fields	NULL
,	NULL
B.	NULL
N.	NULL
,	NULL
Knipe	NULL
,	NULL
D.	NULL
,	NULL
Chanock	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Hirsch	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Melnick	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Monath	NULL
,	NULL
T.	NULL
P.	NULL
&	NULL
Roizman	NULL
,	NULL
B	NULL
.	NULL

(	NULL
Raven	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

1889-1920	NULL
.	NULL

2	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Virology	NULL
,	NULL
eds	NULL
.	NULL

Fields	NULL
,	NULL
B.	NULL
N.	NULL
,	NULL
Knipe	NULL
,	NULL
D.	NULL
,	NULL
Chanock	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Hirsch	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Melnick	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Monath	NULL
,	NULL
T.	NULL
P.	NULL
&	NULL
Roizman	NULL
,	NULL
B	NULL
.	NULL

(	NULL
Raven	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

1921-1957	NULL
.	NULL

3	NULL
.	NULL

Martel-Renoir	NULL
,	NULL
D.	NULL
,	NULL
Grunewald	NULL
,	NULL
V.	NULL
,	NULL
Touitou	NULL
,	NULL
R.	NULL
,	NULL
Schwaab	NULL
,	NULL
G.	NULL
&	NULL
Joab	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76	NULL
,	NULL
1401-1408	NULL
.	NULL

4	NULL
.	NULL

Sixbey	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Nedrud	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Raab-Traub	NULL
,	NULL
N.	NULL
,	NULL
Hanes	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Pagano	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

310	NULL
,	NULL
1225-1230	NULL
.	NULL

5	NULL
.	NULL

Li	NULL
,	NULL
Q.	NULL
X.	NULL
,	NULL
Young	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Niedobitek	NULL
,	NULL
G.	NULL
,	NULL
Dawson	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Birken-bach	NULL
,	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
&	NULL
Rickinson	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
356	NULL
,	NULL
347-350	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Zur	NULL
Hausen	NULL
,	NULL
H.	NULL
,	NULL
Bornkamm	NULL
,	NULL
G.	NULL
,	NULL
Schmidt	NULL
,	NULL
R.	NULL
&	NULL
Hecker	NULL
,	NULL
E.	NULL
(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
76	NULL
,	NULL
782-785	NULL
.	NULL

7	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
&	NULL
Ono	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
445-449	NULL
.	NULL

8	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
Goldfield	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Speck	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
7073-7077	NULL
.	NULL

9	NULL
.	NULL

Laux	NULL
,	NULL
G.	NULL
,	NULL
Freese	NULL
,	NULL
U.	NULL
,	NULL
Fischer	NULL
,	NULL
R.	NULL
,	NULL
Polack	NULL
,	NULL
A.	NULL
,	NULL
Kofler	NULL
,	NULL
E.	NULL
&	NULL
Bornkamm	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Virology	NULL
162	NULL
,	NULL
503-507	NULL
.	NULL

10	NULL
.	NULL

-	NULL
Chang	NULL
,	NULL
Y.	NULL
,	NULL
Dong	NULL
,	NULL
D.	NULL
,	NULL
Hayward	NULL
,	NULL
G.	NULL
&	NULL
Hayward	NULL
,	NULL
SD	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
3358-3369	NULL
.	NULL

11	NULL
.	NULL

-	NULL
Farrell	NULL
,	NULL
P.	NULL
,	NULL
Rowe	NULL
,	NULL
D.	NULL
,	NULL
Rooney	NULL
,	NULL
C.	NULL
&	NULL
Kouzarides	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
127-132	NULL
.	NULL

12	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9459-9463	NULL
.	NULL

13	NULL
.	NULL

Chevallier-Greco	NULL
,	NULL
A.	NULL
,	NULL
Manet	NULL
,	NULL
E.	NULL
,	NULL
Chavrier	NULL
,	NULL
P.	NULL
,	NULL
Mosnier	NULL
,	NULL
C.	NULL
,	NULL
Daillie	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Sergeant	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
3243-3249	NULL
.	NULL

14	NULL
.	NULL

Countryman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82	NULL
,	NULL
4085-4089	NULL
.	NULL

15	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
,	NULL
Shimuzu	NULL
,	NULL
N.	NULL
,	NULL
Sakuma	NULL
,	NULL
S.	NULL
&	NULL
Keating	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

57	NULL
,	NULL
1011-1022	NULL
.	NULL

16	NULL
.	NULL

Manet	NULL
,	NULL
E.	NULL
,	NULL
Gruffat	NULL
,	NULL
H.	NULL
,	NULL
Trescol-Biemont	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Moreno	NULL
,	NULL
I.	NULL
,	NULL
Chambard	NULL
,	NULL
P.	NULL
,	NULL
Giot	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Sergeant	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1819-1826	NULL
.	NULL

17	NULL
.	NULL

-	NULL
Hardwick	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lazarowits	NULL
,	NULL
S.	NULL
&	NULL
Hayward	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
2274-2284	NULL
.	NULL

18	NULL
.	NULL

-	NULL
Gruffat	NULL
,	NULL
H.	NULL
&	NULL
Sergeant	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1172-1178	NULL
.	NULL

19	NULL
.	NULL

Cox	NULL
,	NULL
M.	NULL
,	NULL
Leahy	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Hardwick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
313-321	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Gruffat	NULL
,	NULL
H.	NULL
,	NULL
Duran	NULL
,	NULL
N.	NULL
,	NULL
Buisson	NULL
,	NULL
M.	NULL
,	NULL
Wild	NULL
,	NULL
F.	NULL
,	NULL
Buckland	NULL
,	NULL
R.	NULL
&	NULL
Sergeant	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
46-52	NULL
.	NULL

21	NULL
.	NULL

Quinlivan	NULL
,	NULL
E.	NULL
,	NULL
Holley-Guthrie	NULL
,	NULL
E.	NULL
,	NULL
Norris	NULL
,	NULL
M.	NULL
,	NULL
Gutsch	NULL
,	NULL
D.	NULL
,	NULL
Bachenheimer	NULL
,	NULL
S.	NULL
&	NULL
Kenney	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
1999-2007	NULL
.	NULL

22	NULL
.	NULL

Kenney	NULL
,	NULL
S.	NULL
,	NULL
Holley-Guthrie	NULL
,	NULL
E.	NULL
,	NULL
Mar	NULL
,	NULL
E.	NULL
&	NULL
Smith	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
3878-3883	NULL
.	NULL

23	NULL
.	NULL

-	NULL
Garcia-Blanco	NULL
,	NULL
M.	NULL
&	NULL
Cullen	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
815-820	NULL
.	NULL

24	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
1227-1232	NULL
.	NULL

25	NULL
.	NULL

Sinclair	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Brimmel	NULL
,	NULL
M.	NULL
,	NULL
Shanahan	NULL
,	NULL
F.	NULL
&	NULL
Farell	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
2237-2244	NULL
.	NULL

26	NULL
.	NULL

-	NULL
Zalani	NULL
,	NULL
S.	NULL
,	NULL
Holley-Guthrie	NULL
,	NULL
E.	NULL
,	NULL
Gutsch	NULL
,	NULL
D.	NULL
&	NULL
Kenney	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
7282-7292	NULL
.	NULL

27	NULL
.	NULL

Takimoto	NULL
,	NULL
T.	NULL
,	NULL
Kamide	NULL
,	NULL
M.	NULL
&	NULL
Umeda	NULL
,	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Arch	NULL
.	NULL

Otorhino-laryngol	NULL
.	NULL

239	NULL
,	NULL
87-92	NULL
.	NULL

28	NULL
.	NULL

Glaser	NULL
,	NULL
R.	NULL
&	NULL
O'Neill	NULL
,	NULL
F.	NULL
J	NULL
.	NULL

(	NULL
1972	NULL
)	NULL
Science	NULL
176	NULL
,	NULL
1245-1247	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Microbiology	NULL
:	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

Chevallier-Greco	NULL
,	NULL
A.	NULL
,	NULL
Gruffat	NULL
,	NULL
H.	NULL
,	NULL
Manet	NULL
,	NULL
E.	NULL
,	NULL
Calender	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Sergeant	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
615-623	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
Holley-Guthrie	NULL
,	NULL
E.	NULL
&	NULL
Kenney	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
3816-3823	NULL
.	NULL

Sato	NULL
,	NULL
H.	NULL
,	NULL
Takimoto	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
S.	NULL
,	NULL
Yanaka	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Raab-Traub	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
5295-5300	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

37	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
9199	NULL
Hardwick	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Tse	NULL
,	NULL
L.	NULL
,	NULL
Applegren	NULL
,	NULL
N.	NULL
,	NULL
Nicholas	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Veliuona	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
5500-5508	NULL
.	NULL

Bogedain	NULL
,	NULL
C.	NULL
,	NULL
Alliger	NULL
,	NULL
P.	NULL
,	NULL
Schwarzmann	NULL
,	NULL
F.	NULL
,	NULL
Marschall	NULL
,	NULL
M.	NULL
,	NULL
Wolf	NULL
,	NULL
H.	NULL
&	NULL
Jilg	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
1200-1203	NULL
.	NULL

Ruf	NULL
,	NULL
I.	NULL
K.	NULL
&	NULL
Rawlins	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
7648-7657	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
&	NULL
Speck	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
1217-1226	NULL
.	NULL

Kolman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Taylor	NULL
,	NULL
N.	NULL
,	NULL
Gradoville	NULL
,	NULL
L.	NULL
,	NULL
Countryman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Miller	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

70	NULL
,	NULL
1493-1504	NULL
.	NULL

